Pharmaceutical compositions comprising 3-aminoisoxazolopyridine compounds of the Formula I having IDO1 and/or TDO inhibitory activity are described, where W is CR1, N or N-oxide; X is CR2, N or N-oxide; Y is CR3, N or N-oxide; Z is CR4, N or N-oxide; and at least one of W, X, Y, and Z is N or N-oxide; and R9 and R10 are as defined. Also described are methods of using such compounds in the treatment of various conditions, such as cancer.
描述了包含具有
IDO1和/or TDO抑制活性的
3-氨基异恶唑啉化合物I的药物组合物,其中W是CR1,N或N-氧化物;X是CR2,N或N-氧化物;Y是CR3,N或N-氧化物;Z是CR4,N或N-氧化物;W、X、Y和Z中的至少一个是N或N-氧化物;R9和R10如所定义。还描述了使用这些化合物治疗各种疾病,如癌症的方法。